Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
10

I am worried some folks are supprised about the latest 10q report. What is the difference between this 10q and the previous most recent ones. PTSC has been trading based on the potential favourable Markman outcome. We have had this type of 10q for the past 4 or 6 reports. The hope for a favourable Markman has kept the SP very much alive. The bottomline is I am not selling and I am very hopeful Markman will go in our favor.

This is like a grug on the final stage of FDA approval. If it is approved the stock skyrocket and I am very hopeful Markman will give us a favourable judgement

Please login to post a reply
STEELpulse
City
Rank
Mail Room
Activity Points
16
Rating
Your Rating
Date Joined
04/15/2012
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post